Viewing Study NCT01442168


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-01-24 @ 9:36 PM
Study NCT ID: NCT01442168
Status: TERMINATED
Last Update Posted: 2014-08-19
First Post: 2011-09-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
Sponsor: Modus Therapeutics AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module